Background: Increasing evidence indicates involvement of the pro-inflammatory cytokine TNF-α in hand osteoarthritis (OA) pathogenesis. Ten years clinical and radiologic follow-up of the BeSt study, a randomized trial primarily designed to investigate targeted treatment in rheumatoid arthritis (RA) patients, offered the unique opportunity to study the long-term effects of TNF inhibitors (TNFi) on the development and progression of hand OA. The distal interphalangeal joints (DIPs) are rarely affected in RA, which allowed to evaluate primary OA separately. Objectives: To investigate the effect of TNFi on incidental and progressive radiographic hand OA after 10-year follow-up in recent-onset RA patients. Methods: At baseline and 10-year follow-up 262 patients (mean age 52 years, 66% women) were available for radiologic assessment of hand OA. Eighteen interphalangeal joints (IPs) were scored for osteophytes (OP) using the Osteoarthritis Research Society International (OARSI) atlas (0-3; summated score 0-54), and according to the Kellgren-Lawrence (KL) scoring method (0-4; summated score 0-72). Incidental OA was defined as an increase ≥1 in summated OP score or ≥2 in summated KL score in absence of OA at baseline, and progressive OA as an increase ≥3 in summated OP or KL score in presence of OA at baseline, based on the smallest detectable change. TNFi treatment and disease activity score (DAS) were assessed on standardized visits at a three-monthly interval. Associations between duration of TNFi treatment in months and incidental and progressive OA were analyzed using generalized linear models with Poisson distribution and robust standard errors, while adjusting for age, gender, time averaged DAS, time averaged Sharp-van der Heijde score and hand OA severity at baseline. Results: Based on the OP score, 126 patients (48%) were classified with OA at baseline in the DIPs and 82 patients (31%) in the proximal IPs (PIPs). Incidental OA developed in 33% of patients in DIPs and in 42% in PIPs. Progressive OA occurred in 30% of patients in DIPs and in 38% in PIPs. Of patients with and without OA at baseline, irrespective of joint location, 63% and 55% were treated with TNFi, with a median treatment duration of 47 and 36 months, respectively. (2). Objectives: We hypothesised that hand OA subjects will have structural differences in 3 pain-processing regions of the brain -the anterior cingulate cortex (ACC), insular cortex and thalamus -based on activation of brain centres we have found previously (1). Our brain neuroimaging work was part of a randomised, placebo-controlled trial to assess the effect on clinical pain outcomes by intervention with centrally-acting analgesic agents: pregabalin or duloxetine. Methods: The primary outcome measures for our clinical trial were hand pain Numerical Rating Scale (NRS) and AUSCAN pain after 12 weeks' treatment. In secondary outcome analyses, participants with hand OA (n=28) underwent T1-weighted MRI of the brain before and after 12 weeks of treatment with pregabalin, duloxetine or placebo therapy. Grey matter brain structure was compared using FreeSurfer regional volumetric analysis and voxel-based morphometry (VBM) to age-matched controls (n=11), and evaluated for volume changes in the ACC, insular cortex and thalamus. Results: In our clinical trial, we observed clinically significant improvement in pregabalin, duloxetine and placebo treatment groups after 12 weeks (ANOVA p=0.0078). Most notably, pairwise comparisons for pregabalin vs placebo showed significant improvement for NRS pain and AUSCAN pain outcomes in the ITT analysis (p<0.05), but not for duloxetine vs placebo after 12 weeks' (p>0.05). Both voxel-wise and regional volumetric analyses demonstrated areas of reduced grey matter volume in the ACC of hand OA subjects, relative to control subjects, at baseline (p<0.05) (Figure 1 ). The structural differences in the ACC persisted following 12 weeks of treatment with pregabalin, duloxetine or placebo therapy (p<0.05). We did not observe structural differences in the insular cortex or thalamus in any of the three groups.
Conclusions:
We found that the ACC volume was reduced in participants with hand OA. The ACC is a key pain-processing region of the brain. Changes in ACC grey matter volume have previously been described in other painful conditions, but not hand OA. ACC grey matter volume reduction is thought to represent neural plasticity in chronic pain states. Our data supports the role of central sensitisation in hand OA and provides a rationale for the further investigation of centrallyacting analgesics in its management. Our trial demonstrated improvement in clinical endpoints for pain for pregabalin vs placebo and duloxetine vs placebo, respectively (p<0.05). However, structural differences in the ACC were still evident following 12 weeks of treatment with pregabalin or duloxetine. This may relate to the relatively short duration of treatment in our study. Alternatively, the baseline differences in the ACC may represent irreversible changes. Longitudinal studies with greater follow-up periods are necessary to further investigate this. Background: Osteoarthritis (OA) is one of the most common diseases, caused by a chronic degenerative disorder of the joint. OA can be related to the metabolic syndrome or metabolic abnormalities being recently defined as a subtype of the disease 1 . Matrix-assisted laser desorption/ionization (MALDI) imaging mass spectrometry (IMS) technology allows for the investigation of the bimolecular distribution of proteins, lipids or metabolites through the in situ analysis of tissue sections. In order to better understand the metabolic OA phenotype, the study of the endogenous metabolic profiles using MALDI-IMS should be considered. Objectives: The main goal of this study is to apply MALDI-IMS methodology to study the metabolic spatial distribution of cartilage and to reveal intra-tissue and inter-patient heterogeneity. Methods: Human OA cartilage was obtained from donors undergoing total knee joint replacement. Samples were heat stabilized by a stabilizer system, before being snap frozen. Cartilage punches were sectioned at 12 μm thickness in a cryostat and deposited on indium tin oxide (ITO) glass slides. 9-Aminoacridine (9AA) and N-(1-Naphthyl) Ethylenediamine DihydroChloride (NEDC) matrices were sprayed on the tissues. MALDI-MS profiling and imaging experiments were performed using different mass spectrometers. Data were analyzed by different software dedicated to mass spectrometry. Results: Results showed that 9AA and NEDC matrices were both able to extract several and different compounds. MALDI-MS/MS was employed with 9AA matrix for molecular identification, confirming for the first time the presence of several metabolites in cartilage such as adenosine triphosphate, adenosine diphosphate, uridine triphosphate or N-Acetylglucosamine. Punches from lesioned and nonlesioned areas from the same OA patient were heat stabilized and sprayed with NEDC matrix. MALDI-IMS experiments at 40-μm of spatial resolution showed a different metabolic distribution between deep and superficial areas but also between lesioned and non-lesioned regions suggesting an evidence in the existence of intra-tissue heterogeneity (figure 1).
Conclusions: MALDI-IMS methodology is a useful technique for metabolite profiling of cartilage and could be employed to study OA patient heterogeneity. This fact will be especially relevant for OA patients suffering of metabolic syndrome. Objectives: The aim of this study was to investigate sleep quality in patients with knee osteoarthritis (OA). Methods: One hundred patients with knee OA and age and gender-matched 75 healthy controls were enrolled into the study. Demographic characteristics of the participants were recorded. All patients was examined by a single physician, the findings were recorded. Knee radiographs of the patients were staged according to the Kellgren-Lawrence grading. In addition, to evaluate the clinical status and quality of life of patients was performed Western Ontario ve McMaster Universities Osteoarthritis Index (WOMAC) and Nottingham Health Profile (NHP). The sleep quality of two groups with MOS sleep scale and polysomnography (PSG) were subjectively and objectively evaluated. Results: All scores of MOS sleep scale were significantly lower in patients with knee OA than controls (p<0.001). When PSG outcomes of the patients compared with the controls,waketime during sleep period (WTSP) (37.2±35.9, 13.1±19.4 p=0.012 respectively) and number of awakeness (NOAW) (9.2±18.2, 2.6±3.5, p=0.05 respectively) were significantly higher, sleep efficiency (SE) (84.2±21.1, 96.7±4.6 p=0.009 respectively) was significantly lower in patients with knee OA. There were significantly positive correlations between MOS sleep scale and PSG (sleep period, sleep onset, REM duration and REM latans) outcomes of the patients (r:0.44-0.59 p=0.04-0.006). In addition, MOS sleep scale scores of patients were negatively related with both NHP (pain, emotional reaction, sleep and social isolation subgroup scores) and WOMAC (total and functional) scores (r:-0.20-0.47, p=0.04-0.0001 Background: Osteoarthritis (OA) is a chronic joint disease with complex etiologies characterized by synovial inflammation, subchondral bone remodeling, and the formation of osteophytes, which leads to cartilage deterioration. Periodontitis (PD) is also a chronic inflammatory disease characterized by loss of periodontal ligament and alveolar bone. Recently, the association between OA and metabolic diseases has been proposed, and the association between several systemic diseases such as rheumatoid arthritis, metabolic syndrome and periodontitis has been also revealed. Objectives: The aim of this study was to investigate the association between OA and PD in South Korea using data from the Korea National Health and Nutrition Examination Survey (KNHANES) during 2010-2014. Methods: Cross-sectional data of 7,969 adults who completed the KHANES, and participated in both a periodontal examination and a knee imaging were analyzed. OA of knee was defined when a participant had knee arthralgia and showed radiographic change of Kellgren-Lawrence (KL) grade over 1. OA patients were grouped into mild (KL grade 1-2) and severe (KL grade 3-4) OA. The periodontal status was assessed by the Community Periodontal Index. Binary logistic regression analysis was performed according to the OA and PD status, severity of OA, and subgroups (age, gender) adjusting for the socio-demographics, oral health behaviors and status, smoking, and drinking. Results: Of the 7,969 participants, 1408 (17.7%) had OA and 2987 (37.5%) had PD. OA and PD showed no significant association in overall analysis. However, in subgroup analysis, female patients with severe OA were more likely to have PD (adjusted odd ratio (OR) 1.377, P=0.0316); likewise, OR for severe OA in female patient with PD was 1.367. (P=0.0.54) Conclusions: Severe OA and PD were associated with each other especially in
